COVID-19 vaccine won't be available for children at first
COVID-19 vaccine trials don't currently include children under 12, says Health Canada's chief medical adviser, Supriya Sharma. She says that means vaccination efforts will first focus on adults.
Drugmakers Sanofi and GlaxoSmithKline said Friday that their potential COVID-19 vaccine won't be ready until late next year because they need to improve the shot's effectiveness in older people. Dr. Anthony Fauci says the AstraZeneca and Johnson and Johnson COVID-19 vaccines could be headed toward emergency use authorization in weeks, not months. Dr. Leo Nissola joined CBSN's Anne-Marie Green and Vladimir Duthiers to discuss the vaccine rollout around the country and the Biden administration's ambitious plan to give 100 million doses in 100 days.
CBSN is CBS News' 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the CBS All Access subscription service. British drug company AstraZeneca and Oxford University say late-stage testing of their Covid-19 vaccine shows it is highly effective.
AstraZeneca says its Covid-19 vaccine is 70 percent effective on average and can be stored at normal fridge temperatures. It is easier to distribute and cheaper than its rivals, making it affordable for the developing world.
Al Jazeera's Jonah Hull reports from London, the United Kingdom. The FDA announced it will review Pfizer's request for emergency use authorization of its vaccine on Dec. 10.